Taubman Scholar Dr. Arul Chinnaiyan picked to head prostate cancer "Dream Team"
Stand Up To Cancer (SU2C) and the Prostate Cancer Foundation (PCF), along with the American Association for Cancer Research (AACR), SU2C’s scientific partner, announced the formation of a new Dream Team dedicated to prostate cancer research.
Arul M. Chinnaiyan, M.D., Ph.D., of the University of Michigan Comprehensive Cancer Center, and Charles L. Sawyers, M.D., of Memorial Sloan-Kettering Cancer Center, will lead the Dream Team project titled “Precision Therapy for Advanced Prostate Cancer.” The Dream Team scientists are drawn from five leading prostate cancer clinical research centers in Ann Arbor, New York, Boston, Seattle and London.
The SU2C-PCF Prostate Dream Team Translational Cancer Research Grant will provide funding of $10 million over a three-year period for a seven-center project including both clinical centers and two research infrastructure sites that will address therapeutic interventions for advanced prostate cancer, with special emphasis on metastatic disease, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators.
“Through this unique partnership with PCF, we will focus critically needed research on advanced prostate cancer,” said Sherry Lansing, one of SU2C’s co-founders. “Our collective goal is to produce personalized treatment approaches that will begin to benefit patients in the next few years.”
To read the entire U-M news release, click here.
Help Us Make A Difference. Make A Donation That Could Save Lives.
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman Institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
-
Dr. Eva Feldman discusses stem cell therapies on Michigan Radio
June 14, 2013 -
2013 Taubman Prize
June 05, 2013 -
Stem cell treatment "dramatically slows ALS" in some patients
May 31, 2013
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.
Donors pitch in to keep brilliant science minds at U-M Video
